25 May 2013
News | 21 June 2012
This move could cost $299 million a year for Indian pharma players. | US to charge fee on generic drug sale application.
Click on the link to read the full article at Rediff
(This link will open in a new window)
11 January 2012
24 May 2013
© 2013 thepharmaletter.com